PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Biotechnology and pharmaceutical companies – Market size and forecast 2018-2023
• Hospitals and diagnostic centers – Market size and forecast 2018-2023
• Academic institutes and research organizations – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Rising use of molecular biology kits for disease diagnosis
• Increasing number of applications of molecular biology
• enzymes, kits, and reagents
• Technological advances in the life sciences industry
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Biotechnology and pharmaceutical companies – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Biotechnology and pharmaceutical companies – Year-over-year growth 2019-2023 (%)
Exhibit 21: Hospitals and diagnostic centers – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Hospitals and diagnostic centers – Year-over-year growth 2019-2023 (%)
Exhibit 23: Academic institutes and research organizations – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Academic institutes and research organizations – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies, Inc. – Vendor overview
Exhibit 46: Agilent Technologies, Inc. – Business segments
Exhibit 47: Agilent Technologies, Inc. – Organizational developments
Exhibit 48: Agilent Technologies, Inc. – Geographic focus
Exhibit 49: Agilent Technologies, Inc. – Segment focus
Exhibit 50: Agilent Technologies, Inc. – Key offerings
Exhibit 51: F. Hoffmann-La Roche Ltd – Vendor overview
Exhibit 52: F. Hoffmann-La Roche Ltd – Business segments
Exhibit 53: F. Hoffmann-La Roche Ltd – Organizational developments
Exhibit 54: F. Hoffmann-La Roche Ltd – Geographic focus
Exhibit 55: F. Hoffmann-La Roche Ltd – Segment focus
Exhibit 56: F. Hoffmann-La Roche Ltd – Key offerings
Exhibit 57: Illumina, Inc. – Vendor overview
Exhibit 58: Illumina, Inc. – Product segments
Exhibit 59: Illumina, Inc. – Organizational developments
Exhibit 60: Illumina, Inc. – Geographic focus
Exhibit 61: Illumina, Inc. – Segment focus
Exhibit 62: Illumina, Inc. – Key offerings
Exhibit 63: Merck KGaA – Vendor overview
Exhibit 64: Merck KGaA – Business segments
Exhibit 65: Merck KGaA – Organizational developments
Exhibit 66: Merck KGaA – Geographic focus
Exhibit 67: Merck KGaA – Segment focus
Exhibit 68: Merck KGaA – Key offerings
Exhibit 69: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 70: Thermo Fisher Scientific Inc. – Business segments
Exhibit 71: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 72: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 73: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 74: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 75: Validation techniques employed for market sizing
【掲載企業】
Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc.
【免責事項】
https://www.globalresearch.jp/disclaimer